Home > Balance Sheet > NGL FINECHEM

NGL FINECHEM
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

NGL FINECHEM Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹2.48 Cr₹2.19 Cr₹1.37 Cr₹1.91 Cr₹2.38 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM ?

The latest Deferred Tax Assets / Liabilities ratio of NGL FINECHEM is ₹2.48 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹2.48 Cr
Mar2024₹2.19 Cr
Mar2023₹1.37 Cr
Mar2022₹1.91 Cr
Mar2021₹2.38 Cr

How is Deferred Tax Assets / Liabilities of NGL FINECHEM Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹2.48 Cr
12.85
Mar2024 ₹2.19 Cr
60.15
Mar2023 ₹1.37 Cr
-28.20
Mar2022 ₹1.91 Cr
-19.76
Mar2021 ₹2.38 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,361.9 Cr -6.1% -4.4% 83% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹102,443.0 Cr -4.3% -6.5% -11.9% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-6.1%

-4.4%

83%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses